Abstract
Cyclin H regulates cell cycle transitions; it always forms trimeric cyclin-dependent protein kinases (CDK)-activating kinase (CAK) complex with CDK7 and MAT1 that phosphorylates a threonine residue in the CDK2 T loop region. However, neither the expression nor function of cyclin H in the central nervous system (CNS) injury is still clear. Therefore, we studied cyclin H in a rat spinal cord contusion model. Injury markedly increased cyclin H protein expression throughout the thoracic spinal cord but did not increase CDK7. However, double immunofluorescent staining for proliferating cell nuclear antigen (PCNA) and cell markers revealed increases of cyclin H and CDK2 in proliferating microglia and astrocytes, and the co-immunoprecipitation studies shown that the associations of cyclin H with CDK2 were enhanced evidently after injury. Our data suggest that cyclin H may play a proliferative role in spinal cord injury (SCI).
Similar content being viewed by others
Abbreviations
- BSA:
-
Bovine serum albumin
- CAK:
-
CDK-activating kinase
- CDKs:
-
Cyclin-dependent protein kinases
- CNS:
-
Central nervous system
- DAB:
-
Diaminobenzidin
- ECL:
-
Enhanced chemiluminescence system
- GAPDH:
-
Glyceraldehyde-3-phosphate dehydrogenase
- GFAP:
-
Glial fibrillary acidic protein
- PAGE:
-
Polyacrylamide gel electrophoresis
- PCNA:
-
Proliferating cell nuclear antigen
- SCI:
-
Spinal cord injury
References
Andersen, G., Busso, D., Poterszman, A., Hwang, J. R., Wurtz, J. M., Ripp, R., et al. (1997). The structure of cyclin H: Common mode of kinase activation and specific features. EMBO Journal, 16, 958–967.
Brown, N. R., Noble, M. E., Endicott, J. A., & Johnson, L. N. (1999). The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nature Cell Biology, 1, 438–443.
Dahmus, M. E. (1996). Reversible phosphorylation of the C-terminal domain of RNA polymerase II. Journal of Biological Chemistry, 271, 19009–19012.
Devault, A., Martinez, A. M., Fesquet, D., Labbe, J. C., Morin, N., Tassan, J. P., et al. (1995). MAT1 (‘menage a trois’) a new RING finger protein subunit stabilizing cyclin H-cdk7 complexes in starfish and Xenopus CAK. EMBO Journal, 14, 5027–5036.
Dulic, V., Lees, E., & Reed, S. I. (1992). Association of human cyclin E with a periodic G1-S phase protein kinase. Science, 257, 1958–1961.
Dumont, R. J., Okonkwo, D. O., Verma, S., Hurlbert, R. J., Boulos, P. T., Ellegala, D. B., et al. (2001). Acute spinal cord injury, part I: Pathophysiologic mechanisms. Clinical Neuropharmacology, 24, 254–264.
Elledge, S. J., Richman, R., Hall, F. L., Williams, R. T., Lodgson, N., & Harper, J. W. (1992). CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle. Proceedings of the National Academy of Sciences of the United States of America, 89, 2907–2911.
Fisher, R. P., & Morgan, D. O. (1994). A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell, 78, 713–724.
Gruner, J. A. (1992). A monitored contusion model of spinal cord injury in the rat. Journal of Neurotrauma, 9, 123–126; discussion 126–128
Harper, J. W., & Elledge, S. J. (1998). The role of Cdk7 in CAK function, a retro-retrospective. Genes and Development, 12, 285–289.
Jin, K., Nagayama, T., Chen, J., Stetler, A. R., Kawaguchi, K., Simon, R. P., et al. (1999). Molecular cloning of a cell cycle regulation gene cyclin H from ischemic rat brain: Expression in neurons after global cerebral ischemia. Journal of Neurochemistry, 73, 1598–1608.
Kaldis, P. (1999). The cdk-activating kinase (CAK): From yeast to mammals. Cellular and Molecular Life Sciences, 55, 284–296.
King, R. W., Deshaies, R. J., Peters, J. M., & Kirschner, M. W. (1996). How proteolysis drives the cell cycle. Science, 274, 1652–1659.
Labbe, J. C., Martinez, A. M., Fesquet, D., Capony, J. P., Darbon, J. M., Derancourt, J., et al. (1994). p40MO15 associates with a p36 subunit and requires both nuclear translocation and Thr176 phosphorylation to generate cdk-activating kinase activity in Xenopus oocytes. EMBO Journal, 13, 5155–5164.
Lee, M. H., Reynisdottir, I., & Massague, J. (1995). Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes and Development, 9, 639–649.
Makela, T. P., Tassan, J. P., Nigg, E. A., Frutiger, S., Hughes, G. J., & Weinberg, R. A. (1994). A cyclin associated with the CDK-activating kinase MO15. Nature, 371, 254–257.
Morgan, D. O. (1995). Principles of CDK regulation. Nature, 374, 131–134.
Morgan, D. O. (1996). The dynamics of cyclin dependent kinase structure. Current Opinion in Cell Biology, 8, 767–772.
Morgan, D. O. (1997). Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annual Review of Cell and Developmental Biology, 13, 261–291.
Morris, G. F., & Mathews, M. B. (1989). Regulation of proliferating cell nuclear antigen during the cell cycle. Journal of Biological Chemistry, 264, 13856–13864.
Pines, J. (1993). Cyclins and cyclin-dependent kinases: Take your partners. Trends in Biochemical Sciences, 18, 195–197.
Pines, J. (1995). Cyclins and cyclin-dependent kinases: A biochemical view. Biochemical Journal, 308(Pt 3), 697–711.
Profyris, C., Cheema, S. S., Zang, D., Azari, M. F., Boyle, K., & Petratos, S. (2004). Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiology of Disease, 15, 415–436.
Sherr, C. J., & Roberts, J. M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes and Development, 9, 1149–1163.
Sherr, C. J., & Roberts, J. M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes and Development, 13, 1501–1512.
Solomon, M. J., & Kaldis, P. (1998). Regulation of CDKs by phosphorylation. Results and Problems in Cell Differentiation, 22, 79–109.
Solorzano, L., Rieber, M. S., & Rieber, M. (2000). Lower cyclin H and cyclin-dependent kinase-activating kinase activity in cell cycle arrest induced by lack of adhesion to substratum. Cancer Research, 60, 7114–7118.
Tassan, J. P., Jaquenoud, M., Fry, A. M., Frutiger, S., Hughes, G. J., & Nigg, E. A. (1995). In vitro assembly of a functional human CDK7-cyclin H complex requires MAT1, a novel 36 kDa RING finger protein. EMBO Journal, 14, 5608–5617.
Tator, C. H. (1995). Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathology, 5, 407–413.
Weiss, S., Dunne, C., Hewson, J., Wohl, C., Wheatley, M., Peterson, A. C., et al. (1996). Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. Journal of Neuroscience, 16, 7599–7609.
Yang, H., Lu, P., McKay, H. M., Bernot, T., Keirstead, H., Steward, O., et al. (2006). Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury. Journal of Neuroscience, 26, 2157–2166.
Yankulov, K. Y., & Bentley, D. L. (1997). Regulation of CDK7 substrate specificity by MAT1 and TFIIH. EMBO Journal, 16, 1638–1646.
Acknowledgments
This work was supported by the National Natural Science Foundation of China (No.30671046, No.30770488, No.30870320, No.31070723, No.31071288 and No.81070275); Natural Science Foundation of Jiangsu province (No. BK2009156, No. BK2009157 and No. BK2009161); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Gang Wu and Jianhua Cao contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wu, G., Cao, J., Peng, C. et al. Temporal and Spatial Expression of Cyclin H in Rat Spinal Cord Injury. Neuromol Med 13, 187–196 (2011). https://doi.org/10.1007/s12017-011-8150-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-011-8150-1